Publication | Closed Access

A novel histone deacetylase inhibitor TMU-35435 enhances etoposide cytotoxicity through the proteasomal degradation of DNA-PKcs in triple-negative breast cancer

Tumor BiologyProteasomal DegradationMedicineCell DeathPathologyBreast CancerCancer BiologyTriple-negative Breast CancerAnti-cancer AgentOncologyCell BiologyCancer Research